Literature DB >> 17027858

Autophagic vacuolar myopathy.

Ichizo Nishino1.   

Abstract

Autophagic vacuoles are a frequent feature in numerous neuromuscular disorders. However, they are also pathognomonic morphologic hallmarks in a slowly emerging new group of conditions called autophagic vacuolar myopathies (AVMs), of which Danon disease, originally called "lysosomal glycogen storage disease with normal acid maltase," is the best known entity. Other such conditions, often although not always described from Japan, are X-linked myopathy with excessive authophagy, infantile autophagic vacuolar myopathy, adult-onset autophagic vacuolar myopathy with multiorgan involvement, and X-linked congenital autophagic vacuolar myopathy. Although only 1 protein, the transmembranous lysosomal protein LAMP-2, has been found mutated in Danon disease, the remaining AVMs are genetically still incompletely identified. Several of these conditions not only share autophagic vacuoles, but such autophagic vacuoles also have morphologic properties of the sarcolemma, thus rendering them autophagic vacuoles with sarcolemmal features, an almost pathognomonic phenomenon of this group of disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027858     DOI: 10.1016/j.spen.2006.06.004

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  42 in total

1.  Changes in autophagy after traumatic brain injury.

Authors:  Cindy L Liu; Shaoyi Chen; Dalton Dietrich; Bingren R Hu
Journal:  J Cereb Blood Flow Metab       Date:  2007-12-05       Impact factor: 6.200

Review 2.  Protein misfolding, aggregation, and autophagy after brain ischemia.

Authors:  Tianfei Luo; Yujung Park; Xin Sun; Chunli Liu; Bingren Hu
Journal:  Transl Stroke Res       Date:  2013-11-09       Impact factor: 6.829

Review 3.  Reductive stress in striated muscle cells.

Authors:  Ilaria Bellezza; Francesca Riuzzi; Sara Chiappalupi; Cataldo Arcuri; Ileana Giambanco; Guglielmo Sorci; Rosario Donato
Journal:  Cell Mol Life Sci       Date:  2020-02-18       Impact factor: 9.261

Review 4.  Pros and cons of different ways to address dysfunctional autophagy in Pompe disease.

Authors:  Jeong-A Lim; Naresh Kumar Meena; Nina Raben
Journal:  Ann Transl Med       Date:  2019-07

Review 5.  Mechanism and Regulation of Autophagy and Its Role in Neuronal Diseases.

Authors:  Zhiping Hu; Binbin Yang; Xiaoye Mo; Han Xiao
Journal:  Mol Neurobiol       Date:  2014-10-15       Impact factor: 5.590

6.  Muscle degeneration in neuraminidase 1-deficient mice results from infiltration of the muscle fibers by expanded connective tissue.

Authors:  Edmar Zanoteli; Diantha van de Vlekkert; Erik J Bonten; Huimin Hu; Linda Mann; Elida M Gomero; A John Harris; Giulio Ghersi; Alessandra d'Azzo
Journal:  Biochim Biophys Acta       Date:  2010-04-11

Review 7.  Autophagy and cancer therapy.

Authors:  Paola Maycotte; Andrew Thorburn
Journal:  Cancer Biol Ther       Date:  2011-01-15       Impact factor: 4.742

8.  Late adult-onset of X-linked myopathy with excessive autophagy.

Authors:  Cameron D Crockett; Alessandra Ruggieri; Meena Gujrati; Christopher M Zallek; Nivetha Ramachandran; Berge A Minassian; Steven A Moore
Journal:  Muscle Nerve       Date:  2014-05-17       Impact factor: 3.217

9.  Danon disease: intrafamilial phenotypic variability related to a novel LAMP-2 mutation.

Authors:  Sarah-Louise Cottinet; Anne-Marie Bergemer-Fouquet; Annick Toutain; Frédérique Sabourdy; Zoha Maakaroun-Vermesse; Thierry Levade; Alain Chantepie; François Labarthe
Journal:  J Inherit Metab Dis       Date:  2010-12-16       Impact factor: 4.982

Review 10.  Epigenetic drugs in the treatment of skeletal muscle atrophy.

Authors:  Valentina Guasconi; Pier Lorenzo Puri
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-05       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.